Laura J. Tafe, MD
Title(s)
Professor of Pathology and Laboratory Medicine
Additional Titles/Positions/Affiliations
Assistant Director, Laboratory for Clinical Genomics and Advanced Technology (CGAT), Dartmouth-Hitchcock Medical Center
Department(s)
Pathology and Laboratory Medicine
Education
Medical School:
MD, Wayne State University School of Medicine, Detroit, MI, 2004
Residency:
Dartmouth-Hitchcock Medical Center, Lebanon, NH, Anatomic and Clinical Pathology, 2004-08
Fellowship:
Memorial Sloan-Kettering Cancer Center, New York, NY, Oncologic Pathology, 2008-09
Fellowship:
Memorial Sloan-Kettering Cancer Center, New York, NY, Diagnostic Molecular Pathology, 2009-10
Board Certification:
Anatomic and Clinical Pathology, 2008
Molecular Genetic Pathology, 2011
Websites
http:
Contact Information
Department of Pathology
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon NH 03756
Perineuronal net degradation in aggressive glioblastomas with KANK1::NTRK2 fusions. Limited Availability of Short Tandem Repeat Genotype Testing in the United States for Diagnosis of Partial Hydatidiform Mole: A Dilemma for Practicing Precision Medicine. Optical genome mapping uncovers disease-defining variants in an adult T-lymphoblastic leukemia and impacts prognosis. Lung adenocarcinoma with malignant serous effusions: A comprehensive clinicopathologic, molecular, and outcome analysis. The Utility of Comprehensive Sampling in Cervical Lymph Node Dissection for Head and Neck Squamous Cell Carcinoma: Is More Better? Spindle Cell Rhabdomyosarcoma of Oral Cavity With TCF12::VGLL3 Fusion, Expanding on a Recently Described Entity With Digital Spatial Profiling and Long-Term Follow Up. Optical Genome Mapping Enhances Structural Variant Detection and Refines Risk Stratification in Chronic Lymphocytic Leukemia. Predicting targeted therapy resistance in non-small cell lung cancer using multimodal machine learning. Clinical Implementation of Expanded Solid Tumor Fusion Detection With Whole-Transcriptome Sequencing at an Academic Cancer Center. Clinicopathological and molecular characterization of non-small cell lung cancer with pericardial effusions. |
|